NewslettersCancer Stem Cell NewsMammary Cell News β-Escin Overcomes Trastuzumab Resistance in HER2-Positive Breast Cancer by Targeting Cancer Stem-Like Features By Bob - September 29, 2022 0 The effect of β-escin on trastuzumab-resistant and -sensitive cell lines in vitro was evaluated for apoptosis, expression of HER2 family members, and impact on cancer stem cell-like properties. [Cancer Cell International] Full Article